Aurobindo USA is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Since its first US ANDA approval in 2004, Aurobindo has expanded its portfolio to include more than 150 product families, representing a wide range of therapeutic categories. Aurobindo has been recognized as the fastest growing pharmaceutical company in 2012,* and in early 2013, thanks to the ongoing support of our customers, became one of the top 10 pharmaceutical companies, brand or generic, in terms of total prescriptions dispensed.**
View Top Employees from Aurobindo Pharma USA, Inc.Website | http://www.aurobindousa.com |
Revenue | $276.3 million |
Employees | 1,071 (680 on RocketReach) |
Founded | 1994 |
Address | 279 Princeton Hightstown Rd, East Windsor, New Jersey 08520, US |
Phone | (866) 850-2876 |
Technologies |
JavaScript,
HTML,
PHP
+58 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Artificial Intelligence, Healthcare, Data and Analytics, Science and Engineering, Software, Biotechnology, Pharmaceutical, Health Care |
Web Rank | 1 Million |
Keywords | Generic Drugs, Pharmaceutical Companies, Therapeutic Activities |
Competitors | Alvogen, Cadence Pharmaceuticals - Now a Part of Mallinckrodt Pharmaceuticals, Endo International plc, Lannett Company, Inc., Par Pharmaceutical |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Aurobindo Pharma USA, Inc. employee's phone or email?
The Aurobindo Pharma USA, Inc. annual revenue was $276.3 million in 2024.
Sambamurty Iyer is the CEO of Aurobindo Pharma USA, Inc..
680 people are employed at Aurobindo Pharma USA, Inc..
Aurobindo Pharma USA, Inc. is based in East Windsor, New Jersey.
The NAICS codes for Aurobindo Pharma USA, Inc. are [325, 32].
The SIC codes for Aurobindo Pharma USA, Inc. are [28, 283].